To support growth of the life sciences industry in Southeastern Pennsylvania, BioAdvance established the $20 million Greenhouse Fund to invest in promising proof-of-concept projects related to biotherapeutics, biomedical devices, diagnostics and platform technologies.
The BioAdvance model is an innovative regional solution to the national problem of insufficient seed and pre-seed stage funding. Since making its first Greenhouse Fund investments three and a half years ago, BioAdvance has committed $11.5 million in funding to startup life sciences companies and academic research institution projects. Click here to view company fact sheets.
The Greenhouse Program invests up to $1million in seed-stage companies over the life of an investment. Initial investments are up to $500,000 and BioAdvance also provides its funding recipients with business assistance and critical resources as they grow.
Applicants can be institutions, companies or individuals not affiliated with an organization, and they must be located in, or willing to relocate to, Southeastern Pennsylvania. Applications will be evaluated by technical and business advisors in order to identify the most promising proposals. (For additional information email us at application@bioadvance.com.)

